Basiliximab

Evidence Level: N/A Predicted Indications: 0

Table of Contents

  1. Basiliximab
    1. Pharmacist Assessment Report
    2. Basiliximab: Known uses and market status in India
    3. Summary
    4. Quick overview
    5. Known uses recorded for this drug
      1. Approved (supported by a licence or label)
      2. Related to an approved indication (same disease category)
      3. Relations recorded in the knowledge graph (no approval found)
    6. India Market Information
    7. Safety Considerations
    8. Disclaimer

Pharmacist Assessment Report

Basiliximab: Known uses and market status in India

Summary

The TxGNN model has no candidate with a score of 0.99 or higher for Basiliximab, so there is currently no new predicted indication. The recorded uses of this drug are listed below. They are the drug’s own known uses, not model candidates.

Quick overview

Item Content
New predicted indications None (no model candidate scored 0.99 or higher)
Known uses recorded for this drug 2
Evidence level Not applicable
India Market Status Listed in a compiled Indian medicine price dataset (1 of 1) – CDSCO approval status is not included in this data
Number of Listed Products 1 (valid: 1)

Known uses recorded for this drug

Approved (supported by a licence or label)

Indication Source
graft rejection licence in another country
kidney transplantation licence in another country
Indication Approved category
none none

Relations recorded in the knowledge graph (no approval found)

Indication
none

India Market Information

Licence Product Dosage form Status
201030 Simulect Injection vial of 1 Injection Valid

Safety Considerations

  • Drug Interactions: 69 interactions were identified in the data compiled for this report. Those listed include:
    • Major: adalimumab, baricitinib, certolizumab pegol, and BCG live vaccine (Tice substrain)
    • Moderate: alemtuzumab, alefacept, anakinra, azathioprine, canakinumab, roflumilast, and several vaccines (tetanus toxoid, anthrax, adenovirus type 4, live cholera)
    • Minor: zinc salts (acetate, gluconate, sulfate, chloride)

    The pattern reflects additive immunosuppression and interference with vaccines, especially live vaccines.

Please refer to the package insert for warnings and contraindications.

Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.